Cargando…
miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer
Substance P plays a pivotal role in human cancer development and progression by binding to its receptor, neurokinin-1. Neurokinin-1 has 2 isoforms: full-length neurokinin-1 and truncated neurokinin-1, the latter lacking the cytoplasmic terminal 96-amino acid residues of the full-length protein. We h...
Autores principales: | Zhou, Yu, Wang, Meng, Tong, Yingna, Liu, Xiaobin, Zhang, Lufang, Dong, Dong, Shao, Jie, Zhou, Yunli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740052/ https://www.ncbi.nlm.nih.gov/pubmed/31506061 http://dx.doi.org/10.1177/1533033819875168 |
Ejemplares similares
-
MiR‐34b/c‐5p and the neurokinin‐1 receptor regulate breast cancer cell proliferation and apoptosis
por: Zhang, Lufang, et al.
Publicado: (2018) -
Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients
por: Tong, Yingna, et al.
Publicado: (2017) -
Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression
por: Guan, Mingxiu, et al.
Publicado: (2018) -
MiR-206 regulates the progression of osteoporosis via targeting HDAC4
por: Lu, Zhiyuan, et al.
Publicado: (2021) -
MiR-206-mediated dynamic mechanism of the mammalian circadian clock
por: Zhou, Wei, et al.
Publicado: (2011)